Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
An AI company owned by Google parent company Alphabet, DeepMind, is able to predict future acute kidney injuries and could potentially save lives, according to a new paper published in Nature.
A Harvard-affiliated academic data science center is partnering with a major manufacturer of portable ultrasound systems to boost the diagnostic powers of point-of-care ultrasound, aka “POCUS,” using AI.
Not only is AI aiding recovery for some of the sickest hospitalized patients—those in the ICU—but it’s also making work less stressful for the medical professionals who care for them.
In the wake of Alexa’s success at gaining HIPAA-compliant medical skills, AI developers are working to offer smart speakers that do everything from warning homebound people they’re having a heart attack to taking clinical notes for physicians during patient visits.
AI and deep learning can extract molecular markets of breast cancer from tissue morphology and assist pathologists in a mass-scale molecular profiling, according to new research published in JAMA Network Open.
Deep reinforcement learning enabled by AI can help physicians figure out whether opioids would truly be better than other interventions for patients suffering pain in intensive care units.
The venture arm of 32-hospital UnityPoint Health is partnering with VIDA Diagnostics, investing $1 million to fine-tune and broaden the use of VIDA’s AI software for flagging signs of trouble in lung images.
The power of AI in medicine has come to light in Alabama, where an 11-year-old in medical peril had the good fortune to have a dad who’s an AI-specialized computer programmer working in healthcare.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
